Martijn Simons

7PUBLICATIONS
21CO-AUTHORS
Epidemiological methodsPredictive and prognostic markersEpidemiological modellingMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 21, 2024
Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective.

Takao Takeshima, Fumihiko Sakai, Xinyu Wang

|Mar 04, 2024
A cost-consequence model of using the 21-gene assay to identify patients with early-stage node-positive breast cancer who benefit from adjuvant chemotherapy in the Netherlands.

Martijn J H G Simons, Peter M Machielsen, Jelle A Spoorendonk

|Jan 09, 2024
Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy.

|Jun 15, 2023
Modeling Monthly Migraine-Day Distributions Using Longitudinal Regression Models and Linking Quality of Life to Inform Cost-Effectiveness Analysis: A Case Study of Fremanezumab in Japanese-Korean Migraine Patients.

Xinyu Wang, Kentaro Yamato, Yoshitsugu Kojima

|Feb 09, 2023
Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands.

Zakile A Mfumbilwa, Janneke A Wilschut, Martijn J H G Simons

|Aug 18, 2021
Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer.

Martijn J H G Simons, Valesca P Retèl, Bram L T Ramaekers

Pageof 2

Frequent Collaborators

4 joint publications

Valesca Retèl

3 joint publications

Bram Ramaekers

3 joint publications

Zakile A Mfumbilwa

3 joint publications

Veerle M H Coupé